Imunon, Inc. (IMNN) Form S-1/A — Oct 27, 2026
Imunon filed Amendment No. 1 to its Form S-1 (File No. 333-299647) on October 28, 2026, solely to add exhibits including the Maxim Group placement agency agreement and form securities purchase agreement. The documents describe a registered best-efforts offering of units, each consisting of one share (or a pre-funded warrant) plus Tranche A, B, C and D common warrants covering 3.5x the base shares purchased.
Key figures
- Warrant cover
- Tranche A 0.5x, Tranche B 1.0x, Tranche C 1.0x, Tranche D 1.0x of shares/pre-funded warrants sold
- Placement agent fee
- 7.0% of gross proceeds
- Placement agent warrants
- 5.0% of base offering shares, exercise at 110% of unit price, 5-year term
- Expense reimbursement cap
- $125,000 if offering closes; $25,000 if not
- Lockup officers directors 5pct
- executed lock-up agreements required
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.